Diagnostic capability of multidetector CT for arterioportal shunt in hepatocellular carcinoma.
- Author:
Ming-yue LUO
1
;
Hong SHAN
;
Zai-bo JIANG
;
Lu-fang LI
;
Hui-qing HUANG
;
Jian-sheng ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Angiography, Digital Subtraction; Arteriovenous Fistula; diagnostic imaging; etiology; Carcinoma, Hepatocellular; complications; diagnostic imaging; Female; Hepatic Artery; abnormalities; diagnostic imaging; Humans; Liver Neoplasms; complications; diagnostic imaging; Male; Middle Aged; Portal Vein; abnormalities; diagnostic imaging; Tomography, Spiral Computed; methods
- From: Chinese Journal of Oncology 2004;26(4):231-233
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the capability of multidetector CT (MDCT) for the diagnosis of arterioportal shunt (APS) associated with hepatocellular carcinoma (HCC).
METHODSTwo hundred and eighty-two patients with HCC were examined by both enhanced thin slice MDCT scanning in early hepatic arterial phase, late hepatic arterial phase, portal venous phase and digital subtraction angiography (DSA). The criteria for diagnosis of APS: (1) Earlier enhancement or stronger opacification of main portal trunk and/or the first order branches compared with that of superior mesenteric vein or splenic vein; (2) Earlier enhancement or stronger opacification of the second order and smaller portal venous branches compared with that of main portal trunk. The presence and degree of APS demonstrated with MDCT and DSA were analysed by double blind method.
RESULTSIn 282 HCC patients, 56 were complicated with APS. MDCT demonstrated central APS in 48 patients with 41 severe and 7 moderate shunt, one revealing no APS by DSA due to the giant HCC focus. Among 7 patients with light peripheral APS, two lesions were not revealed by DSA due to faint shunt and the last lesion in the patient with mixed APS was revealed both by APS and DSA.
CONCLUSIONMultidetector CT was a simple, effective and noninvasive new technique for the diagnosis of arterioportal shunt associated with hepatocellular carcinoma.